酮洛芬分子印迹拆分及分离过程热力学研究

利用非共价分子印迹法,采用4-乙烯基吡啶为功能单体,以二甲基丙烯酸乙二 醇酯为交联剂,在模板分子（S）-酮洛芬的存在下,制备出（S）-酮洛芬的分子印 迹聚合物（MIPs）,并用作HPLC固定相,对其进行了高效液相色谱评价。结果表明 外消旋酮洛芬在制备的印迹柱上得到了有效的分离,（S）-酮洛芬的容量因子 k_s'为9.52,选择性因子α为1.52,分离度R为0.88。此外,HPLC分析表明制备的 MIPs能够分离结构相似的酮洛芬、布洛芬和萘普生。研究了流动相中乙酸浓度、流 速及温度对拆分效果的影响,测定了分离过程中的焓变、熵变和自由能变化,对分 子印迹分离过程作了进一步解释。     

紫外光聚合法制备L-DBTA手性分子印迹聚合物的研究Ⅱ.聚合物性能

以丙烯酸为功能单体,二苯甲酰-L-酒石酸(L-DBTA)为模板分子,三羟甲基丙烷三丙烯酸酯(TMPTA)为交联剂,采用紫外光聚合方法合成了L-DBTA手性分子印迹聚合物.通过HPLC表征,表明合成的手性分子印迹聚合物对L-DBTA模板分子具有很好的识别性,L-DBTA的选择性比二苯甲酰-D-酒石酸(D-DBTA)高.通过Scatchard分析表明,L-DBTA手性分子印迹聚合物中只存在一类影响聚合物识别能力的结合位点.293.15K时,结合位点的平衡离解常数为0.064mmol/L,最大表现结合容量为6.4mg/g.MIPs结合热力学研究表明,印迹分子L-DBTA与分子印迹聚合物手性识别基团之间的识别机理可以用Langmuir等温吸附描述,结合热力学参数为△H=7.40 kJ/mol,△S=42.74 J/(mol·K),△G298=-5.34kJ/mol.L-DBTA与MIPs相互作用速率快,表观活化能为7.40 kJ/mol.     

利多卡因分子印迹聚合物的制备及其在固相萃取中的应用

以利多卡因(LD)分子印迹聚合物为研究体系,利用分子模拟计算功能单体与模板分子之间的相互作用能,并通过作用实验加以验证,确定衣康酸为最佳单体。以乙二醇二甲基丙烯酸酯为交联剂,N,N-二甲基甲酰胺(DMF)为溶剂,采用本体聚合法合成分子印迹聚合物(MIP);采用高效液相色谱检测。实验发现,聚合物具有较高的印迹指数和选择性;在乙腈加载、5%甲醇-乙腈淋洗、5%HCl-甲醇洗脱条件下,聚合物具有最佳印迹效果。通过渗漏实验考察聚合物键合容量。实验发现,在乙腈溶液中每100mg MIP与空白聚合物(NIP)可分别键合1.62和0.92mg LD分子;采用光度法测定牛血清中利多卡因的含量,其平均回收率达到84.6%。     

修饰硅胶表面印迹牛血红蛋白及其识别性能的研究

本文选用马来酸酐修饰后的硅胶作为载体,丙烯酰胺为功能单体,N,N’-亚甲基双丙烯酰胺为交联剂,牛血红蛋白为模板分子,采用氧化还原悬浮聚合法,合成了具有选择性识别的牛血红蛋白分子印迹聚合物。并用红外光谱(IR)、扫描电子显微镜(SEM)对聚合物进行了表征,结果表明载体表面成功接枝了分子印迹聚合物薄层。同时,选择性吸附实验表明分子印迹聚合物的具有良好的识别性能,能成功的实现水溶液中牛血红蛋白的富集。     

分子印迹聚合物选择性降低烟气中稠环芳烃类物质

以芘(PYR)为模板,由热引发本体聚合合成了芘分子印迹聚合物(MIP),考察了印迹聚合物的选择性吸附性能,采用Scatchard模型分析了印迹聚合物的结合特性,用离线固相萃取实验考察了印迹聚合物对同类底物的吸附能力,并将芘分子印迹聚合物应用到卷烟滤嘴中,用GC/MS法考察了卷烟主流烟气中稠环芳烃类物质释放量的变化。结果表明,芘分子印迹聚合物具有选择性降低卷烟烟气中稠环芳烃类物质的功能,当MIP添加量为1.5 mg时,能将卷烟烟气中的苯并[a]芘(B[a]P)、苯并(a)蒽(B[a]A)和苣(CHR)的释放量分别降低31.08%、25.69%和27.33%。     

三唑酮分子印迹预组装体系的分子模拟与吸附性能

以三唑酮为模板分子, 以丙烯酰胺(AM)、 丙烯酸(AA)、 甲基丙烯酸(MAA)和三氟甲基丙烯酸(TFMAA)为功能单体预组装了分子印迹聚合物体系, 采用半经验法和从头算法, 利用Hyperchem软件模拟了三唑酮与4种功能单体所组成的分子印迹预组装体系的构型、 能量、 反应配比及复合反应的结合能, 选择复合物结合能最高的功能单体用于分子印迹聚合物的合成. 采用密度泛函方法计算了模板与单体在不同致孔剂中的溶剂化能. 结果表明, 三唑酮与三氟甲基丙烯酸所形成复合物的作用力最强, 在非极性溶剂中溶剂化能最弱. 由预组装体系的差示紫外光谱法研究发现, 一分子三唑酮可与两分子三氟甲基丙烯酸在氯仿中形成氢键复合物, 与分子模拟的结果一致. 在最佳模拟条件下, 合成了三唑酮的印迹聚合物, 利用吸附等温线Langmuir和Freundlich模型研究了印迹聚合物的吸附行为及识别机理. 上述方法对于分子印迹体系的筛选及分子印迹聚合物性能的预测有重要的意义.     

分子印迹整体柱在高校液相色谱和电色谱手性分离中的应用

在常规不锈钢色谱管中以甲基丙烯酸为功能单体,采用原位聚合法制备了(5S,11S)-特罗格尔碱(S-TB)的印迹整体柱.考察了流动相中添加不同量的醋酸和水对分离的影响,结合台阶梯度洗脱模式在S-TB整体柱上实现了对TB消旋体的快速分离.另外,以碱性单体2-二甲基乙基胺甲基丙烯酸酯(DAMA)为功能单体,在毛细管中采用原位聚合法制备了毛细管分子印迹整体柱,用于在毛细管电色谱(CEC)中对消旋体1,1'-联-2-萘酚(BNL)进行手性分离.结果表明,以DAMA为功能单体可以制备其他酸性模板的分子印迹聚合物,从而扩大了分子印迹聚合物(MIP)在CEC分离中的应用范围.     

分子印迹聚合物选择性降低烟气中稠环芳烃类物质

以芘(PYR)为模板,由热引发本体聚合合成了芘分子印迹聚合物(MIP),考察了印迹聚合物的选择性吸附性能,采用Scatchard模型分析了印迹聚合物的结合特性,用离线固相萃取实验考察了印迹聚合物对同类底物的吸附能力,并将芘分子印迹聚合物应用到卷烟滤嘴中,用GC/MS法考察了卷烟主流烟气中稠环芳烃类物质释放量的变化。 结果表明,芘分子印迹聚合物具有选择性降低卷烟烟气中稠环芳烃类物质的功能,当MIP添加量为1.5 mg时,能将卷烟烟气中的苯并[a]芘(B[a]P)、苯并(a)蒽(B[a]A)和苣(CHR)的释放量分别降低31.08%、25.69%和27.33%。     

手性药物(S)-布洛芬氢键自组装印迹聚合物识别机理

以含有单一结合基团的手性药物(S)-布洛芬作为模板分子,制备了系列印迹聚合物.采用紫外-可见光谱和红外光谱对印迹及识别机理进行了研究.结果表明,模板分子与功能单体分别通过形成蓝移氢键和红移氢键完成预组装过程和再识别吸附过程,且形成了主客体配比为1∶1的配合物.等温吸附实验结果表明,印迹聚合物对模板分子表现出明显的选择性吸附,特异性吸附容量为37.92μmol/g,印迹指数为3.06,且印迹聚合物内特定的三维空间结构对其特异性吸附性能具有显著影响.由手性分离实验考察了印迹聚合物的拆分性能,其对(R)-布洛芬的分离因子为1.79.     

样品前处理新介质的研究进展

1印迹聚合物在样品前处理中的应用分子印迹聚合物(molecularly imprinted polymer,MIP)是指目标分子(模板分子)与功能单体通过共价键或非共价键作用预组装,与交联剂共聚制备得到的聚合物。     

Enantiomeric purity determination of ketoprofen by capillary electrophoresis: development and validation of the method

A simple, fast capillary electrophoresis method for determining the total ketoprofen content in an oral pharmaceutical formulation is proposed. The addition of 75 mM of heptakis(tri- O-methyl)-beta-cyclodextrin to the background electrolyte allows the quantitation of the enantiomeric impurity of ( R)-(-)-ketoprofen contained in the formulation. A relative limit of detection is proposed as a measure of the lowest detectable enantiomeric impurity and the results show that the method can detect the minor enantiomer at levels as low as 0.04% in ( S)-(+)-ketoprofen. The chiral method was validated following ICH recommendations and the quality parameters obtained show the suitability of the proposed method. The analysis of samples examined during the course of a stability study under chiral and achiral conditions revealed that the total ketoprofen content did not change significantly with time and the enantiomeric impurity range was 0.1-0.4%.     

Chiral separation of ketoprofen on an achiral NH<Subscript>2</Subscript> column by HPLC using vancomycin as chiral mobile phase additive

A high-performance liquid chromatographic method for chiral separation of ketoprofen racemate was developed. (R)- and (S)-ketoprofen enantiomers were separated on a LiChrosorb NH₂ column (250 mm × 4.6 mm, i.d 5 µm) at 20 °C, using 2-propanol/potassium dihydrogen phosphate buffer (pH 6.0, 0.05 M) (50:50 v/v). Containing vancomycin as the mobile phase, at a flow rate of 0.8 ml min^?1 and detection wavelength of UV, the detector was set at 310 nm. Under these conditions, ketoprofen enantiomers could be separated with a selectivity factor (α) of 2.172 and a resolution (Rs) of 4.78 using extremely low concentrations of the vancomycin chiral additive.     

Enantiomeric Composition Tests of Ketoprofen in Equine Plasma and Urine as Diastereomeric (S)-(-)-1-Phenylethylamides by Achiral GC–MS

The enantiomeric composition of ketoprofen in equine plasma and urine after administration of a commercial racemic ketoprofen product were determined as diastereomeric (S)-(-)-1-phenylethylamidation by achiral gas chromatography–mass spectrometry in selected ion monitoring mode. This method showed linearity (r ≥ 0.9986) over the range tested (5.0–5,000 ng), with acceptable precision (% RSD ≤ 9.5) and accuracy (% RE = ?3.7–7.3). The ratio of (S)-ketoprofen in plasma after 6.0 h and in urine after 71.0 h increased progressively to final values of 67.3 ± 0.1 and 91.9 ± 2.2%, respectively, attributable to the inversion of (R)-ketoprofen to (S)-ketoprofen.     

Diastereoselectivity and site dependency in the photochemistry of ketoprofen in the bovine serum albumin matrix

The photodegradation of the S(+)- and R(-)-ketoprofen (KP) enantiomers in the bovine serum albumin matrix was studied by steady-state photolysis with the use of lambda(irr) > 320 nm and transient absorption spectroscopy with lambda(exc) = 355 nm, at 1/1 and 2/1 KP/BSA molar ratios. R(-)-KP was found to be more labile than S(+). Triplet ketoprofen species were evidenced with lifetimes of 400 ns for S(+) and 600 ns for R(-)-KP. Further longer-lived transients with lifetimes of 2.6 and 6.0 mus for S(+) and R(-), respectively, were detected. On the basis of the binding constants of the drug enantiomers to the two main binding sites of the protein, obtained from circular dichroism experiments, the individual disappearance quantum yields of the 1:1 and 2:1 diastereomeric KP:BSA complexes could be estimated. The photoreactivity in the BSA matrix was rationalized on the basis of diastereoselective photodecarboxylation in the two main protein sites.     

Determination of (R)- and (S)-ketoprofen in human plasma by liquid chromatography/tandem mass spectrometry following automated solid-phase extraction in the 96-well format

A sensitive and selective method was developed for the determination of (R)-ketoprofen ((R)-kt) and (S)-ketoprofen ((S)-kt) in human plasma using chiral liquid chromatography/tandem mass spectrometry (LC/MS/MS). Plasma samples spiked with stable-isotope-labeled [(13)C(1), (2)H(3)]-(R and S)-ketoprofen, for use as the internal standards, were prepared for analysis using automated solid-phase extraction (SPE) in the 96-well microtiter format. The enantiomers were separated on an (R)-1-naphthylglycine and 3,5-dinitrobenzoic acid (Chirex 3005) 250x2.0 mm i.d. analytical column, equipped with a 30x2.0 mm i.d. guard column using isocratic mobile phase conditions. The (R)- and (S)-kt levels were quantifiable from 0.05 to 2500 ng ml(-1) by constructing two separate curves from calibration standards covering the same range. The first curve ranged from 0.05 to 100 and the second from 100 to 2500 ng ml(-1). A concentration of 0.05 ng ml(-1) of either enantiomer was easily detected using a 1 ml plasma sample volume. The average method accuracy, evaluated at four levels over an extended period, was better than +/-3% over the entire range. The precision for the same set of quality control samples ranged from 4.0 to 7.0 % RSD (n = 24). The method was applied to the evaluation of pharmacokinetic parameters in human plasma obtained from volunteers who received 25 mg of kt by peroral administration of Actron caplets or by topical administration of Oruvail gel.     

Enantioselective analysis of ibuprofen, ketoprofen and naproxen in wastewater and environmental water samples

A highly sensitive and reliable method for the enantioselective analysis of ibuprofen, ketoprofen and naproxen in wastewater and environmental water samples has been developed. These three pharmaceuticals are chiral molecules and the variable presence of their individual (R)- and (S)-enantiomers is of increasing interest for environmental analysis. An indirect method for enantioseparation was achieved by the derivatization of the (R)- and (S)-enantiomers to amide diastereomers using (R)-1-phenylethylamine ((R)-1-PEA). After initial solid phase extraction from aqueous samples, derivatization was undertaken at room temperature in less than 5 min. Optimum recovery and clean-up of the amide diastereomers from the derivatization solution was achieved by a second solid phase extraction step. Separation and detection of the individual diastereomers was undertaken by gas chromatography-tandem mass spectrometry (GC-MS/MS). Excellent analyte separation and peak shapes were achieved for the derivatized (R)- and (S)-enantiomers for all three pharmaceuticals with peak resolution, R(s) is in the range of 2.87-4.02 for all diastereomer pairs. Furthermore, the calibration curves developed for the (S)-enantiomers revealed excellent linearity (r(2) ≥ 0.99) for all three compounds. Method detection limits were shown to be within the range of 0.2-3.3 ng L(-1) for individual enantiomers in ultrapure water, drinking water, surface water and a synthetic wastewater. Finally, the method was shown to perform well on a real tertiary treated wastewater sample, revealing measurable concentrations of both (R)- and (S)-enantiomers of ibuprofen, naproxen and ketoprofen. Isotope dilution using racemic D(3)-ibuprofen, racemic D(3)-ketoprofen and racemic D(3)-naproxen was shown to be an essential aspect of this method for accurate quantification and enantiomeric fraction (EF) determination. This approach produced excellent reproducibility for EF determination of triplicate tertiary treated wastewater samples.     

Enantioseparation of (R,S)-ketoprofen using Candida antarctica lipase B in an enzymatic membrane reactor

An enzymatic membrane reactor (EMR) for enantioseparation of (R,S)-ketoprofen via Candida antarctica lipase B (CALB) as biocatalyst was investigated. A comparative study of free and immobilized CALB was further conducted. The catalytic behaviour of CALB in an EMR was affected by the process parameters of enzyme load, substrate concentration, substrate molar ratio, lipase solution pH, reaction temperature, and substrate flow rate. Immobilization of CALB in the EMR was able to reduce the amount of enzyme required for the enantioseparation of (R,S)-ketoprofen. Immobilized CALB in the EMR assured higher reaction capacity, better thermal stability, and reusability. It was also found to be more cost effective and practical than free CALB in a batch reactor.     

Excited state enantiodifferentiating interactions between a chiral benzophenone derivative and nucleosides

Time-resolved measurements using nanosecond laser flash photolysis have revealed significant enantiodifferentiation in the interaction between ketoprofen (a chiral benzophenone derivative) and two relevant nucleosides, namely, thymidine and 2'-deoxyguanosine. In both cases, the highest quenching rate constants have been observed for (R)-ketoprofen, the enantiomer with lower pharmacological activity. Photoproduct studies performed in the case of thymidine suggest that the enantiodifferentiating process corresponds to a Paterno-Büchi reaction, leading to the formation of oxetanes. With 2'-deoxyguanosine, the quenching is associated with an electron-transfer process monitored through the generation of a ketyl radical.     

An HPLC-DAD and LC-MS study of condensation oscillations with S(+)-ketoprofen dissolved in acetonitrile

In our earlier studies, a spontaneous chiral conversion of the selected low-molecular-weight carboxylic acids (i.e., amino acids, hydroxy acids, and profen drugs) dissolved in aqueous ethanol medium, running in vitro was described. Then it became clear that this spontaneous chiral conversion is accompanied by the spontaneous condensation of the discussed compounds. With several acids, it was established that this condensation is also oscillatory in nature. The theoretical models were developed aiming to give a rough explanation of the observed non-linear processes. In this paper, the results of these studies on the dynamics of condensation with S(+)-ketoprofen, a very popular profen drug, when stored for certain amount of time dissolved in a non-aqueous medium (i.e., acetonitrile) is presented. These investigations were carried out with the aid of two independent high-performance liquid chromatographic systems with the diode array detection and of a third high-performance liquid chromatographic system equipped with mass spectrometric detection. In one cycle of chromatographic measurements, it was possible to monitor condensation of S(+)-ketoprofen in 25-min intervals for 30 h, thus obtaining kinetic information on the progress of this process. Mass spectrometric detection confirmed the presence of new species in the stored solution with molecular weights much higher than that of S(+)-ketoprofen, which can be attributed to the condensation products. The obtained data show that condensation of S(+)-ketoprofen dissolved in acetonitrile progresses in a rapid manner, and that the observed oscillatory concentration changes with S(+)-ketoprofen and with the main condensation product characterize with an irregularity and shallow amplitudes. A theoretical model was referenced that jointly describes the oscillatory chiral conversion and the oscillatory condensation with the low-molecular-weight chiral carboxylic acids.